PANDEMRIX H5N1 pandemic influenza vaccine (split virion, inactivated, AS03 adjuvanted) 2.5 mL injection suspension vial composit

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

Influenza virus haemagglutinin, Quantity: 3.75 microgram

Inapatikana kutoka:

GlaxoSmithKline Australia Pty Ltd

INN (Jina la Kimataifa):

Influenza virus haemagglutinin

Dawa fomu:

Injection, suspension

Tungo:

Excipient Ingredients: water for injections; polysorbate 80; magnesium chloride hexahydrate; sodium chloride; thiomersal; potassium chloride; dibasic sodium phosphate dodecahydrate; octoxinol 10; monobasic potassium phosphate

Njia ya uendeshaji:

Intramuscular

Vitengo katika mfuko:

50

Dawa ya aina:

(S4) Prescription Only Medicine

Matibabu dalili:

Prophylaxis of influenza in an officially declared pandemic situation. PANDEMRIX H5N1 should be used in accordance with official recommendations.

Bidhaa muhtasari:

Visual Identification: Colourless light opalescent liquid; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 5 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Idhini hali ya:

Registered

Idhini ya tarehe:

2008-06-24